Evidence map›Paper›PMID 19560990›Full record

ReviewMolecular oncology2009

At the crossroads of polarity, proliferation and apoptosis: the use of Drosophila to unravel the multifaceted role of endocytosis in tumor suppression.

Thomas Vaccari, David Bilder

Open access · bronzeAbstract readReview
In one paragraph

Review in Molecular oncology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 53 citations in OpenAlex.

  1. Unveiling the Tumor Suppressors: Insights from Drosophila.Advances in experimental medicine and biology · 2025
    Review
  2. Notch Signaling in Drosophila Tumor Models.Advances in experimental medicine and biology · 2025
    Review
  3. Article
  4. Review
  5. Review
  6. Tumorigenesis and cell competition inProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  7. The Initial Stage of Tumorigenesis in Drosophila Epithelial Tissues.Advances in experimental medicine and biology · 2019
    Review
  8. Article
  9. Genetic and Cell Biology Methods to Study ESCRTs in Drosophila melanogaster.Methods in molecular biology (Clifton, N.J.) · 2019
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. JAK/STAT pathway dysregulation in tumors: a Drosophila perspective.Seminars in cell & developmental biology · 2014
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Thomas VaccariDepartment of Molecular and Cell Biology, University of California, Berkeley, CA, USA. thomas.vaccari@ifom-ieo-campus.it
David Bilder
IFOM · ITUniversity of California, Berkeley · US

Funding

Regulation of Drosophila Epithelial PolarityR01GM068675 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI BILDER, DAVID · 2003 to 2017
$3.9M
NIGMS NIH HHS R01 GM068675NIGMS NIH HHS R01GM068675
6 · The paper itself

Abstract

Endocytosis is an important regulator of cell-cell signaling and endocytic trafficking has been increasingly implicated in control of tumor suppression. Recent insights from Drosophila indicate that impairment of multiple trafficking steps which lead to receptor degradation can cause tumor formation in epithelial organs. These tumors are characterized by sustained activation of a number of mitogenic signaling pathways, and by subversion of epithelial polarity and the apoptotic response. Cooperation between such alterations, as well as tumor-host interactions, is also observed. The recapitulation of several hallmarks of human cancers in fly tumors provides a framework to understand the role of defective endocytosis in cancer.

Indexed as

Cell ProliferationAnimalsApoptosisCell PolarityDrosophilaEndocytosisHumansModels, BiologicalNeoplasms

Identifiers

PMID19560990
PMCPMC2755045
OpenAlexW2008348839

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.